Nuvalent, Inc.
NUVLNASDAQHealthcare● Active
$90.95
$-3.07(-3.27%)
Market Cap$6.7B
P/E Ratio—
52W High$113.015
52W Low$71.13
Nuvalent, Inc. (NUVL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NUVL · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.31B | $0.22B | $0.11B | $0.06B | $0.04B |
| G&A Expenses | $0.11B | $0.06B | $0.04B | $0.02B | $0.01B |
| Total Operating Expenses | $0.41B | $0.28B | $0.15B | $0.09B | $0.05B |
| Operating Income | ($0.41B) | ($0.28B) | ($0.15B) | ($0.09B) | ($0.05B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.04B | $0.04B | $0.02B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.02B | $0.00B | $0.00B |
| Income Before Tax | ($0.42B) | ($0.26B) | ($0.13B) | ($0.08B) | ($0.05B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.43B) | ($0.26B) | ($0.13B) | ($0.08B) | ($0.05B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-5.85 | $-3.93 | $-2.17 | $-1.65 | $-2.13 |
| Wtd Avg Shares | 0.07B | 0.07B | 0.06B | 0.05B | 0.02B |
| EBITDA | ($0.01B) | $0.00B | ($0.13B) | ($0.09B) | ($0.05B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Nuvalent, Inc. data
About Nuvalent, Inc. (NUVL) Income Statement
Nuvalent, Inc. (NUVL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NUVL reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.43B) — a net profit margin of —.
Frequently asked questions
NUVL · 4 questionsNuvalent, Inc. (NUVL) reported revenue of $0.00B for 2025, down —% year-over-year.
NUVL revenueNUVL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08